Acute effects of insulin in the control of VLDL production in humans: Implications for the insulin-resistant state

Diabetes Care

Volumn 19, Issue 4, 1996, Pages 390-393

  Lewis, Gary F ^a   Steiner, George ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; C PEPTIDE; FATTY ACID; GLUCAGON; GLUCOSE; GLYCEROL; HEPARIN; HYDROCORTISONE; INSULIN; INTRALIPID; TOLBUTAMIDE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; CONFERENCE PAPER; DIABETES MELLITUS; FATTY ACID METABOLISM; HORMONE ACTION; HUMAN; HUMAN CELL; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; LIVER CELL; LIVER METABOLISM; NONHUMAN; RAT;

EID: 0029865259     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.4.390     Document Type: Conference Paper

References (38)

1. Gibbons GF: Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J 268:1-13, 1990
2. Sparks JD, Sparks CE Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biophys Biochim Acta 1215:9-32, 1994
3. Lewis GF, Uffelman KD, Szeto L, Weller B, Steiner G: Interaction between free fatty acids (FFA) and insulin in the acute control of very low density lipoprotein (VLDL) production in humans. Clin Invest 95:158-166, 1995
4. 2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin. Biochem J 288:101-107, 1992
5. Bonadonna RC, Groop LC, Zych K, Shank M, DeFronzo RA. Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans. Am J Physiol 259 E736-E750, 1990
6. Coppack SW, Jensen MD, Miles JM In vivo regulation of lipolysis in humans J Lipid Res 35:177-193, 1994
7. Howard BV: Lipoprotein metabolism in diabetes mellitus J Lipid Res 28:613-628, 1987
8. Egusa G, Beltz WF, Grundy SM, Howard BV: Influence of obesity on the metabolism of apolipoprotein B in humans J Clin Invest 76:596-603, 1985
9. Streja DA, Marliss EB, Steiner G: The effects of prolonged fasting on plasma triglyceride kinetics in man Metabolism 26 505-516, 1977
10. Reaven GM, Greenfield MS. Diabetic hypertriglyceridemia: evidence for three clinical syndromes. Diabetes 30 (Suppl. 2):66-75, 1981
11. Steiner G, Haynes FJ, Yoshino G, Vranic M: Hyperinsulinemia and in vivo very-low-density-triglyceride kinetics. Am J Physiol 246:E187-E192, 1984
12. Shapiro ET, Polonsky KS, Copinschi G, Bosson D, Tillil H, Blackman J, Lewis G, Van Cauter E: Nocturnal elevation of glucose levels during fasting in non insulin dependent diabetes mellitus. J Clin Endocrinol Metab 72:444-454, 1991
13. Reaven GM, Hollenbeck C, Yeng C-Y, Wu MS, Chen YD: Measurement of plasma glucose, free fatty acid, lactate and insulin for 24 hr in patients with NIDDM. Diabetes 37:1020-1024, 1988
14. Martin-Sanz P, Vance JE, Brindley DN: Stimulation of apolipoprotein secretion in very-low-density and high density lipoproteins from cultured rat hepatocytes by dexamethasone. Biochem J 271:575-583, 1990
15. 2: effects of oleic acid and insulin. J Lipid Res 28: 423-426, 1987
16. Durrington PN, Newton RS, Weinstein DB, Steinberg D: Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest 70:63-73, 1982
17. Hermier D, Hales P, Brindley DN: Biphasic effects of glucagon and cyclic AMP on the synthesis and secretion of lipids by rat hepatocytes Biochem J 279:705-709, 1991
18. Sparks JD, Sparks CE, Miller LL Insulin effects on apolipoprotein B production by normal, diabetic and treated diabetic rat liver and cultured rat hepatocytes Biochem J 261:83-88, 1989
19. Salhanick AI, Schwartz SI, Amatruda JM. Insulin inhibits apolipoprotein B secretion in isolated human hepatocytes. Metabolism 40:275-279, 1991
20. Sparks CE, Sparks JD, Bolognino M, Salhanick A, Strumph PS, Amatruda JM: Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primarily cultures of rat hepatocytes. Metabolism 35:1128-1136, 1986
21. Duerden JM, Bartlett SM, Gibbons GF: Long-term maintenance of high rates of very-low-density lipoprotein secretion in hepatocyte cultures: a model for studying the direct effects of insulin and insulin deficiency in vitro. Biochem J 263:937-943, 1989
22. Patsch W, Franz S, Schonfeld G: Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J Clin Invest 71: 1161-1174, 1983
23. Jackson TK, Salhanick AI, Elovson J, Deichman ML, Amatruda JM: Insulin regulates apolipoprotein B turnover and phosphorylation in rat hepatocytes. J Clin Invest 86:1746-1751, 1990
24. Bartlett SM, Gibbons GF: Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes: a biphasic effect of insulin Biochem J 249:37-43, 1988
25. 2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res 30:1065-1077, 1989
26. 2 cells. Biochem J 280:99-104, 1991
27. 2 cells. Biochem Cell Biol 70:1301-1312, 1992
28. Lewis GF, Uffelman KD, Szeto LW, Steiner G: Effects of acute hyperinsulinemia on very low density lipoprotein (VLDL) triglyceride and VLDL apolipoprotein (apo) B production in normal weight and obese individuals. Diabetes 42:833-842, 1993
29. Lewis GF, Zinman B, Uffelman KD, Szeto L, Weller B, Steiner G VLDL production is decreased to a similar extent by acute portal and systemic hyperinsulinemia in humans. Am J Physiol 267:E566-E572, 1994
30. Wang CS, Fukuda N, Ontko JA: Studies on the mechanism of hypertriglyceridemia in the genetically obese Zucker rat. J Lipid Res 25:571-579, 1984
31. Salhanick AI, Deichman ML, Amatruda JM Chronic in vivo and acute in vitro effects of insulin on apolipoprotein B synthesis and secretion in rat hepatocytes (Abstract) Diabetes 41 (Suppl. 1):17A, 1992
32. Lewis GF, Steiner G, Polonsky KS, Weller B, Zinman B: A new method for comparing portal versus peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion. J Clin Endocrinol Metab 78:66-70, 1994
33. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41: 368-377, 1992
34. Lewis GF, O'Meara NM, Soltys PA, Blackman JD, Iverius PH, Druetzler AF, Getz GS, Polonsky KS: Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat loading test. J Clin Endocrinol Metab 71: 1041-1050, 1990
35. Karpe K, Steiner G, Olivecrona T, Carlson LA, Hamsten A: Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest 91:748-758, 1993
36. Lewis GF, O'Meara NM, Soltys PA, Blackman JD, Iverius PH, Pugh WL, Getz GS, Polonsky KS. Fasting hypertriglyceridemia in non-insulin-dependent diabetes mellitus (NIDDM) is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocnnol Metab 72: 934-944, 1991
37. Gibbons GF, Bartlett SM, Sparks CE, Sparks JD: Extracellular fatty acids are not utilized directly for the synthesis of very-low-density lipoproteins in primary cultures of rat hepatocytes. Biochem J 287: 749-753, 1992
38. Wiggins D, Gibbons GF: The lipolysis/ esterification cycle of hepatic triacylglycerol: its role in the secretion of very-low-density lipoprotein and its response to hormones and sulphonylureas Biochem J 284:457-462, 1992